Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts by Gombos, Imre et al.
Membrane-Lipid Therapy in Operation: The HSP Co-
Inducer BGP-15 Activates Stress Signal Transduction




2, Burcin Gu ¨ngo ¨r
1, Zsolt To ¨ro ¨k
1,G a ´bor Balogh





1,A ´ kos Hunya
4, Noe ´mi To ´th
1, Zsuzsanna Literati-
Nagy
1,L a ´szlo ´ Vı ´gh Jr.
1, Attila Glatz
1, Mario Brameshuber




7, Ibolya Horva ´th
1,L a ´szlo ´ Vı ´gh
1*
1Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary, 2Department of Pharmaceutical and Biomedical Sciences,
University of Salerno, Salerno, Italy, 3Department of Biosciences, Abo Akademi University, Turku, Finland, 4LipidArt Ltd, Szeged, Hungary, 5Institute of Applied Physics,
Vienna University of Technology, Vienna, Austria, 6Department of Medicine, Division of Endocrinology, University of California, Los Angeles, Los Angeles, California,
United States of America, 7Cellular and Molecular Metabolism Laboratory, Baker Heart and Diabetes Institute, Prahran, Victoria, Australia
Abstract
Aging and pathophysiological conditions are linked to membrane changes which modulate membrane-controlled
molecular switches, causing dysregulated heat shock protein (HSP) expression. HSP co-inducer hydroxylamines such as BGP-
15 provide advanced therapeutic candidates for many diseases since they preferentially affect stressed cells and are unlikely
have major side effects. In the present study in vitro molecular dynamic simulation, experiments with lipid monolayers and
in vivo ultrasensitive fluorescence microscopy showed that BGP-15 alters the organization of cholesterol-rich membrane
domains. Imaging of nanoscopic long-lived platforms using the raft marker glycosylphosphatidylinositol-anchored
monomeric green fluorescent protein diffusing in the live Chinese hamster ovary (CHO) cell plasma membrane
demonstrated that BGP-15 prevents the transient structural disintegration of rafts induced by fever-type heat stress.
Moreover, BGP-15 was able to remodel cholesterol-enriched lipid platforms reminiscent of those observed earlier following
non-lethal heat priming or membrane stress, and were shown to be obligate for the generation and transmission of stress
signals. BGP-15 activation of HSP expression in B16-F10 mouse melanoma cells involves the Rac1 signaling cascade in
accordance with the previous observation that cholesterol affects the targeting of Rac1 to membranes. Finally, in a human
embryonic kidney cell line we demonstrate that BGP-15 is able to inhibit the rapid heat shock factor 1 (HSF1) acetylation
monitored during the early phase of heat stress, thereby promoting a prolonged duration of HSF1 binding to heat shock
elements. Taken together, our results indicate that BGP-15 has the potential to become a new class of pharmaceuticals for
use in ‘membrane-lipid therapy’ to combat many various protein-misfolding diseases associated with aging.
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Introduction
A hallmark of stressed cells and organisms is the elevated
synthesis of the ubiquitous and highly conserved heat shock
protein (HSP) molecular chaperones. The protein quality control
and the operation of various stress protection machineries require
strict signaling modalities and transcriptional programs which are
altered in a number of prominent disease states and, therefore,
play a fundamental role in their pathology. Typically, an
aberrantly high level of HSPs is characteristic in cancer, and the
converse situation applies for aging, type-2 diabetes or neurode-
generation. Understanding those mechanisms whereby mamma-
lian cells can elicit a stress protein response is of key importance
and forms the base for the design of new drugs with the ability to
modulate the level of a particular HSP [1].
Besides heat shock, many chemicals can induce HSP expression
in a temperature- independent manner [2]. Some compounds,
including non-toxic hydroxylamine (HA) derivatives [1,3], may
not induce the classical heat shock protein response per se, but
rather amplify the expression of HSPs induced by mild physical or
pathophysiological stresses. Therefore, HSP co-inducers are
unique drug candidates because they may enhance HSP
expression in diseased cells, without significantly affecting healthy
cells [1,3,4]. HA derivatives, such as Bimoclomol, Arimoclomol
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28818and BRX-220, are effective in the treatment of wound healing in
diabetic complications in rats [5], and in delaying the progression
of the fatal neurodegenerative condition amyotrophic lateral
sclerosis [6]. We have recently shown that another HA derivative
NG-094 is remarkably effective at alleviating polyQ-dependent
paralysis in C. elegans and confers protection against polyQ
proteotoxicity even if administered after disease onset, by a
mechanism involving HSF1-controlled expression of molecular
chaperones [7]. In addition, we have also demonstrated that the
HA derivative BGP-15 improves insulin sensitivity in genetic- or
diet-induced obesity [8] while others have demonstrated that it
protects against tachypacing-induced contractile dysfunction in a
Drosophila model for atrial fibrillation [9].
There is a growing body of evidence linking the production of
HSPs, triggered by exposure to different kinds of environmental
stress conditions, to changes in the lipid composition and in the
architecture of membranes [10–13]. This ‘‘membrane sensor’’
hypothesis predicts that, besides protein denaturation or alteration
in nucleic acid conformation, stress protein signals may originate
from the cellular membranes [1,10]. It has been proposed that,
rather than the overall changes in the physical state of membranes
per se, the remodeling of specific microdomains, locally formed
nonbilayer structures, and/or changes in the composition of
particular lipid molecular species involved directly in specific lipid-
protein interactions, are potentially and equally able to furnish
stimuli for the activation or attenuation of heat shock genes. A
plasma membrane-associated HSP response-refining signal can be
related to the altered operation of various membrane-localized
receptor proteins, transmitters, lipases or other molecules [14,15].
Further supporting the view that lipid rafts can be considered to
be scaffolds of heat shock response (HSR), the raft-localized sterol
glucosyltransferase-driven formation of cholesteryl glucoside (CG),
an established HSP-inducing lipid mediator, was shown to be
induced before the activation of the heat shock transcription factor
(HSF1) [16]. Interestingly, the glycosylation of cholesterol
diminishes the ability of the sterol to reside in lateral domains
constituted by membrane lipids having highly ordered hydrocar-
bon chains [17].
In the present study we addressed the mode of action of the HA
derivative BGP-15. Hypothesizing that the drug may affect the
properties of membranes, by using molecular dynamics (MD)
simulations [18] we provided the first evidence on the docking of
BGP-15 into model membranes made of sphingomyelin-choles-
terol (SM-Chol). The specific interaction of BGP-15 with Chol-
containing membranes was further assessed using a combination
of complementary biophysical approaches. Chol depletion with
methyl-b-cyclodextrin (MBCD) is commonly employed to estab-
lish the involvement of lipid rafts in a cellular process. A strongly
reduced rate of Chol depletion by MBCD caused by BGP-15
addition was documented in vitro by Langmuir monolayer
technique. By applying the novel, in vivo ‘‘thinning out clusters
while conserving the stoichiometry of labeling’’ (TOCCSL)
method, which allows imaging of nanoscopic long-lived platforms
with raft-like properties diffusing in the live cell plasma membrane
[19], we have shown the preservation of raft integrity challenged
by mild heat stress in cells pretreated with the HSP co-inducer.
Redistribution of Chol-rich membrane domains upon drug
administration was followed by a fluorescein ester of polyethylene
glycol-derivatized Chol (fPEG-Chol) probe. Inhibition of the small
GTPase protein Rac1 [20] demonstrates a profoundly attenuated
HSP co-inducing effect of BGP-15. Although the detailed
mechanism remains to be elucidated, Rac1 is suggested to be a
key element of BGP-15- driven stress signaling pathway upstream
of HSF1. We have previously shown that the co-inducing effect of
Bimoclomol on HSP expression is mediated via the prolonged
activation of HSF1 [21]. Recent studies revealed that the
activation of the sirtuin 1 deacetylase (SIRT1) can prolong
HSF1 binding to the promoters of heat shock genes by
maintaining HSF1 in a more deacetylated, DNA-binding
competent state [22]. Thus, we addressed the possible effect of
BGP-15 on the regulation of heat-induced acetylation of HSF1.
Paradoxically, in 293T cells treated with heat shock alone, an
enhanced level of acetylated HSF1 was detected, which returned
to baseline during the stress recovery period. BGP-15, however,
prevented the heat-induced increase observed in the level of HSF1
acetylation. Finally, we demonstrate that BGP-15 is not a direct
modulator of the deacetylase factor SIRT1.
Results
BGP-15 partitions into the lipid membranes: molecular
dynamics simulation studies
MD simulations can provide insight into molecular mechanisms
associated with the action of a drug and can offer key information
about the interactions of a drug with presumptive target
biomolecules and have long been used to explore binding,
permeation, and accumulation of relevant molecules in mem-
branes [18]. Figure 1A represents an MD snapshot of the
interaction of the drug with an asymmetric SM/Chol model
membrane. Figure 1B shows the docking of BGP-15 molecules at
the water-lipid interface. The BGP-15 molecules reach the bilayer
by diffusion and snorkel just under the level of SM phosphorous in
the subsequent 5 ns of simulation. This interaction between the
drug and the model membrane modifies the relative spatial
positioning of its constituents as highlighted by the changes of the
density profile (Figure 1B).
Effect of BGP-15 on the cholesterol depletion in lipid
monolayers
Chol release rate is a good measure of the chemical activity of
Chol in the membrane [23]. To test whether BGP-15 could have a
direct effect on the stability of membrane rafts, we used Langmuir
lipid monolayers. The release rate of dihydrocholesterol (DChol)
to MBCD from lipid monolayers was measured at constant surface
pressure [24]. This technique allows the direct measurement of the
removal of DChol from the monolayers by monitoring the
decrease in monolayer area. A typical experiment is shown in
Figure 2A. In the experiments, DChol rather than Chol was used
in order to minimize possible artifacts due to Chol oxidation [23].
DChol and Chol have very close chemical structures and DChol is
often preferred because of its better stability [25]. Control
experiments showed no difference when comparing Chol with
DChol. Desorption of DChol from a mixed monolayer containing
DChol/SM=1/1 was markedly slower compared with desorption
from pure Chol monolayers (Figure 2A). SM removal from the
monolayer was negligible since MBCD addition to pure SM
monolayer resulted in a very slow decrease in monolayer area.
Addition of BGP-15 underneath a DChol/SM=1/1 monolayer
has no effect on the surface pressure (data not shown), however,
the desorption of DChol from the monolayer to MBCD decreased
at a low 5 mM concentration of BGP-15 in the subphase
(Figure 2B). This observation suggests that, in the presence of
BGP-15 the chemical activity of DChol decreased indicating an
increased stability of Chol/SM complexes.
HSP Co-Inducer BGP-15 Remodels Lipid Rafts
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stress observed by direct imaging of nanoscopic long-
lived rafts in the plasma membrane of live CHO cells
While lipid rafts are known to play a crucial role in many
signaling processes, relatively little is known regarding their
stability, composition or heterogeneity. Importantly, however,
activation of the HSR using mild thermal stress coincides with
membrane raft reorganization [13], suggesting that the two are
directly linked. Recently, we described a novel method, TOCCSL,
which allows the direct imaging of nanoscopic long-lived platforms
with raft-like properties diffusing in the live cell plasma membrane
[19]. Our method senses these platforms by their property to
assemble a characteristic set of fluorescent marker proteins or
lipids on a time-scale of seconds. In CHO cells stably expressing
the consensus raft marker glycosylphosphatidylinositol-anchored
monomeric green fluorescent protein (mGFP-GPI), we detected
Chol-dependent mGFP-GPI oligomers diffusing as stable units in
the plasma membrane [19]. Most importantly, in the course of
these studies we also noted that exposure to a mild heat stress
(39uC) led to the disappearance of mGFP-GPI homo-association,
supporting the idea that the plasma membrane is acutely sensitive
to small temperature elevations. We measured the changes in the
fraction of mGFP-GPI homo-associates in CHO cells subjected to
39.5uC over a time course of 45 min (Figure 3). As expected, the
initial cluster fraction dropped to approximately one-third within
10 min at this temperature. BGP-15 pretreatment, however,
prevented this early heat-induced raft destabilization indicating
Figure 1. Molecular dynamics simulation of BGP-membrane
interaction. A) Position of atoms and molecules in SM/Chol
membrane after 5 ns of simulation. SM is blue, Chol is yellow, all other
atoms of the components and BGP-15 are colored using the Yasara CPK
scheme. B) The position of BGP-15 molecules (in red) and the structural
changes of SM/Chol membranes after addition of BGP-15. The control
membrane is indicated with 2; the membrane upon addition of BGP-15
is indicated with +.
doi:10.1371/journal.pone.0028818.g001
Figure 2. Effect of BGP-15 on DChol desorption from lipid
monolayers to MBCD. A) MBCD-mediated removal of DChol from
lipid monolayers at constant lateral surface pressure. When indicated
10 mM BGP-15 was injected into the subphase underneath SM/DChol
monolayer 5 min before MBCD was administered. Surface area was
measured before (A0) and at the indicated time points after (At) MBCD
injection. B) Effect of BGP-15 concentration on MBCD-mediated DChol
desorption from SM/DChol monolayers. The monolayers were equili-
brated with BGP-15 for 5 min before MBCD was injected into the
subphase.
doi:10.1371/journal.pone.0028818.g002
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labeled nanoscopic platforms challenged by thermal stress. The
spontaneous recovery of raft integrity in control cells observed by
the end of the experimental period likely demonstrates the
operation of stress-adaptive raft remodeling, as we discussed
recently [12,26].
BGP-15 affects both the level and the size distribution of
cholesterol-rich surface membrane microdomains in heat
shock response-defective melanoma cells
When added to live cells, fPEG-Chol is distributed exclusively in
the outer plasma membrane leaflet and partitioned preferentially
to Chol-rich membrane microdomains [27]. In addition, when
mammalian cell number increases beyond a certain level, cells are
less stress-inducible for a specific set of HSPs [28].
Our results demonstrated that fPEG-Chol is a sensitive and
specific probe for unraveling the effect of BGP-15 on the level and
size distribution of Chol-rich microdomains in B16-F10 cells. We
next assumed that by increasing the chemical activity of Chol,
BGP-15 could affect both the level and organization of sterol-rich
fPEG-Chol-stained raft domains. According to our model subtle
membrane perturbations are critically involved in the conversion
of signals from the environment into the transcriptional activation
of stress genes. Consistent with this model, when B16-F10 cells
were cultured with distinct initial cell densities, we observed
marked losses of polyene (especially arachidonic acid) containing
lipid molecular species with a concomitant monoene production in
conjunction with increasing initial cell number (M.P., G.B., I.H.
and L.V. unpublished). Our parallel investigations concerning the
inducibility of selected hsp genes by RT-PCR also revealed that,
together with the lipid molecular species remodeling, such a
variation in cell culture conditions seriously affected both the
amplitude and profile of HSR (for hsp25 see later). By using the
fPEG-Chol reporter, rafts were imaged by an ultra-sensitive
fluorescence microscope in total internal reflection (TIRF) mode
and the detected microdomains were ranged in size (diameter) of
300–2500 nm. Most importantly, parallel with the experimentally
induced reduction of HSR by increasing the initial cell density in
the culture (low initial cell number, LCN: 0.75610
6 vs. high initial
cell number, HCN: 6610
6), the total membrane area covered by
fPEG-Chol-positive raft domains decreased by more than 50%
(Figure 4A) compared with that measured in LCN counterparts.
Importantly, however, 60 min pre-treatment with BGP-15 to
the HCN sub-population significantly ameliorated this effect
(Figure 4A). Apart from this effect, administration of BGP-15
also led to a slight alteration in the size distribution of fPEG-Chol-
labeled microdomains, separated into six classes on the basis of
their diameter (Figure 4B). Exclusively in HCN possessing low
HS responding capacity, BGP-15 increased the size of membrane
rafts at the expense of the smaller ones. Of note, a very similar
effect was previously observed following either non-lethal heat
priming or after the addition of the HSP inducer benzyl alcohol to
B16-F10 cells [13]. In respect of the level and size distribution of
membrane microdomains, BGP-15 treatment in HSR-defective
HCN melanoma populations resulted in a remarkable similarity to
that found in the highly HS-responsive LCN cells. Drug
administration rescued the HSR of HCN cells, as highlighted by
the two-fold elevation of the expression of hsp25 gene (Figure 4C).
Together, these findings suggest that such a drug-induced recovery
detected both in the level and size distribution pattern of Chol-rich
rafts is very likely coupled to the triggering of raft-associated stress
sensing and signaling pathways.
Rac1 is a key element of BGP-15-driven stress signaling
The Rho family of small GTPases (Rac, Rho, Cdc42) functions
as binary switches in various signaling pathways ranged from
controlling cell proliferation, differentiation or stress response [20].
Analogous to shear or oxidative stress, moderate heat shock was
shown to induce the surface membrane translocation of Rac1 and
membrane ruffling in a Rac1-dependent manner, whereas
increased HSP expression was paralleled by the activation of
HSF1 [29]. Rac1 cycles between the inactive GDP-bound and the
active GTP-bound states and its plasma membrane translocation
and activation is strongly dependent on membrane Chol content
[20]. Integrin signals are known to target Rac1 to Chol-enriched
membrane microdomains, where it interacts with downstream
effectors [30]. We assumed that since active Rac1 binds
preferentially to Chol-rich membranes, and this binding step is
specifically determined by the composition and physical state of
raft lipids, BGP-15 may affect Rac1 signaling via its interaction
with raft constituent lipids. Accordingly, we treated cells with
NSC233766, a compound that has been previously shown to
specifically inhibit Rac1 GDP/GTP exchange activity by
interfering with the interaction between Rac1 and guanine
nucleotide exchange factors (GEFs) [31]. Inhibiting Rac1 in this
manner diminished heat induced (41.5uC) hsp25 expression by
approximately 50% (Figure 5). When cells were heated to 41.5uC
and co-treated with BGP-15, the mRNA level of hsp25 was
markedly increased above that of heat treatment alone. Impor-
tantly, this effect was blocked by co-treatment with NSC233766
providing clear evidence that the BGP-15-mediated HSP
activation is Rac1-dependent. Thus, our data describe a novel
mechanism by which HAs, specifically BGP-15, drive stress
signaling upstream of HSF1 involving activation of the Rho
family member Rac1.
Figure 3. The effect of BGP-15 on the temperature-induced
change in cluster fraction of mGFP-GPI. CHO cells stably
expressing mGFP-GPI were subjected to 39.5uC with or without
10 mM BGP-15. TOCCSL experiments were performed and at indicated
times the cluster fraction (two or more fluorophores per domain) was
calculated [n=2 error bars represent standard error of the mean (SEM)].
doi:10.1371/journal.pone.0028818.g003
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early phase of heat stress
We have previously demonstrated that the HSP co-inducing
effect of the HA Bimoclomol is mediated via the prolonged
binding of HSF1 to the respective DNA elements [21]. Recently,
deacetylation of HSF1 by SIRT1 on Lysine-80 was identified as a
novel molecular mechanism resulting in prolonged binding of
HSF1 to heat shock element (HSE) [22]. We therefore speculated
Figure 4. The effect of BGP-15 on cholesterol-rich membrane domains and the heat shock inducibility of hsp25 in B16-F10 cells with
different cell density. A) Fluorescence intensity of fPEG-Chol in B16-F10 cells seeded with low (LCN, 1.5610
6/10 cm plate) or high cell number
(HCN, 6610
6/10 cm plate with or without 10 mM BGP-15). Student’s t-test was used for statistical analyses, and p=0.05 was set as a significance
threshold. B) The size distribution profile of membrane microdomains labeled by fPEG-Chol in HCN (with or without 10 mM BGP-15) and LCN cells and
imaged by TIRF microscopy. C) HCN (with or without 10 mM BGP-15) and LCN cells were heated at 42uC for 1 hour and the expression of hsp25 was
tested by RT-PCR.
doi:10.1371/journal.pone.0028818.g004
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acetylation status of HSF1. To test this hypothesis, a FLAG-tagged
mouse HSF1 construct was used to analyze global HSF1
acetylation. Cells exposed to heat shock at 42uC over a 60 min
period gradually increased the HSF1 acetylation level compared to
untreated (37uC) cells (Figure 6A), suggesting paradoxically a
stress-triggered attenuation of HSF1-binding on HSE. However,
co-treatment with BGP-15 and heat shock for 60 min resulted in a
significantly lower acetylated HSF1 level, even when measured
immediately after heat exposure (Figure 6B).
HSF1 is known to be deacetylated by SIRT1 [22]. To exclude a
direct influence of BGP-15 on the SIRT1 enzymatic activity, a
commercially available fluorimetric SIRT1-activity assay specifi-
cally designed to measure the lysyl deacetylase activity of
recombinant SIRT1 was used. In this in vitro assay, a peptide
comprising amino acids 379–382 of human p53, a known in vivo
target of SIRT1 activity (Arg-His-Lys-Lys[Ac]), is used as a
substrate for a recombinant SIRT1 enzyme. As such, the
generated fluorescence signal is proportional to the amount of
deacetylation of the lysine corresponding to Lys-382. As expected,
the presence of Resveratrol, a known SIRT1 inducer, resulted in
an almost three-fold increase while the presence of Suramin, a
known SIRT1 inhibitor, resulted in a three-fold lower SIRT1
activity compared with baseline control, respectively. Addition of
10 mM BGP-15 to the reaction resulted in a similar fluorescence
signal compared with control, suggesting no direct modulation of
SIRT1 activity by BGP-15 (Figure 6C). Taken together, BGP-15
prevents the heat-induced immediate acetylation of HSF1 by a
hitherto unknown mechanism, rather than via directly affecting
the enzyme activity of SIRT1.
Discussion
For decades, sensing temperature changes in eukaryotes has
exclusively been attributed to the formation of unspecified
thermolabile proteins, whose unfolding recruits inhibitory chap-
Figure 5. Hsp25 mRNA expression in B16-F10 cells modified by
Rac1 inhibitor and BGP-15 administration. B16-F10 cells were
pretreated or not by Rac1 inhibitor NSC23766 for 2 hours before 1 h
41.5uC heat shock with or without 10 mM BGP-15. RNA was isolated and
the expression of hsp25 was tested by RT-PCR. [n=3, error bars
represent standard error of the mean (SEM)].
doi:10.1371/journal.pone.0028818.g005
Figure 6. Effect of BGP-15 treatment on heat-induced HSF1
acetylation in HEK293T cells and on in vitro SIRT1 activity. A)
HEK293T cells transiently co-transfected with mouse HSF1-FLAG and
p300 were heat shocked for different lengths of time at 42uC or for
60 min at 42uC followed by 60 min recovery (R). After immunoprecip-
itation by FLAG, samples were probed for acetylated lysin by western
blotting [n=3, error bars represent standard error of the mean (SEM)];
B) Samples were or were not treated with 10 mM BGP-15 for 60 min
before and during 60 min heat shock or 60 min recovery following heat
shock (R) Acetylated HSF1 was determined as above. [n=4, p,0.05,
error bars represent standard error of the mean (SEM)]; C) In vitro
activity of SIRT1 using activators, inhibitors and BGP-15 [n=3, error bars
represent standard error of the mean (SEM)].
doi:10.1371/journal.pone.0028818.g006
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repressed HSFs [32]. Recent findings not only allowed a better
understanding of the early cellular events that take place at the
early phase of temperature rise or other stresses to timely express
HSPs, but pointed unambiguously also to membranes as
additional cellular sensors in activating a HSR from prokaryotes
to mammalian cells [2]. Plasma membrane is not just a barrier
separating the cell from its environment but its protein and lipid
constituents also coordinate the incoming and outgoing signals
[33]. Remodeling of surface membranes initiated either by heat
stress or by non-proteotoxic membrane lipid-interacting chemicals
can induce generation, transduction, and deactivation of stress
signals through global effects on the physical properties (like
fluidity) of the membrane matrix [26].
Besides sensing changes in the nanostructure and physical-
chemical state of membranes induced directly by stress conditions
per se, the plasma membrane may also act as a sensor of specific
intra- and extracellular protein aggregates, and consequently
activate HSP chaperones to reduce aggregate toxicity for
membranes [34]. The primary heat stress signals generated in
membranes are likely transduced by several transduction pathways
[35] and will, however, coalesce predominantly into the activation
of HSFs, the expression of HSPs and the onset of cellular
thermotolerance [1].
A conclusive picture of HSF1 activation during heat shock and
other stresses is yet to be obtained [36]. The activated HSFs would
provide the specificity of HSR: the basic stress signal can be as
variable as the form of cellular stress stimuli. Aging or
pathophysiological conditions can also be linked to the develop-
ment of subtle membrane changes or ‘‘membrane-defects’’
modulating the operation of such above- described, HSP-refining,
membrane-based and/or membrane-controlled ‘‘molecular
switches’’, causing ultimately dysregulated expression of HSPs.
As we defined earlier, a chaperone co-inducer is a substance
that cannot induce HSPs by itself, but can enhance HSP induction
in combination with other mild stresses. A chaperone co-inducer
also has the ability to lower the temperature threshold of the HSR
[3]. HAs, such as BGP-15 may provide suitable therapeutic
candidates for many disease states since they are capable of
affecting stressed rather than unstressed cells and, therefore, they
are unlikely to have major side effects as is the case with many
classes of current drugs.
The importance of membrane lipids as major therapeutic
targets has grown in recent years [37]. This progress is
undoubtedly highlighted by the introduction of the concept of
‘‘lipid therapy’’, in which a drug molecule acts on a membrane to
primarily change the membrane structure [38]. Interestingly, the
idea of lipid therapy is similar in spirit to the recent concept
discussed for the mechanism of general anesthetics [39]. It is
noteworthy that anesthetics could play a role in the activation of
membrane proteins by changing the pressure profile of a lipid
membrane and some of those (like benzyl alcohol) are established
HSP inducers [11,13]. Our studies uniformly indicate that BGP-
15 is able to permeate into the surface membranes and to associate
prefentially to Chol-enriched lipid platforms. Direct imaging of
nanoscopic long-lived platforms with raft-like properties diffusing
in the plasma membrane of live mGFP-GPI-transfected CHO cells
[19] showed Chol-dependent mGFP-GPI cluster formation.
Whereas immediately after exposing cells to temperatures
corresponding to fever-stress, the mGFP-GPI clusters almost
completely disappeared, while this effect was completely counter-
acted by the administration of BGP-15. Studies are underway to
unravel more precisely how BGP-15 affects the stress-induced raft
destabilization/restabilization process, i.e. to participate in the
protein and lipid remodeling within membrane nanoplatforms,
which is supposed to control the efficacy of the generation and
transduction of stress signals towards hsp genes.
Next we documented, that the BGP-15-enhanced activation of
HSP expression involves the Rac1 signaling cascade in accordance
with the previous observation that membrane Chol profoundly
affects the targeting of Rac1 to membranes [20]. It was suggested,
that stress-stimulated, PI-3-kinase-driven conversion of PIP2 to
PIP3 activates the small GTP-binding protein Rac1 under mild,
non-denaturing heat stress conditions, which in turn stimulates
NADPH oxidase by producing H2O2 [40]. To explore the
importance of signaling mechanisms including lipid peroxidation
as a possible subsequent avenue of such a Rac1-dependent
oxidative burst coupled with signaling mechanisms affecting HSP
expression is presently underway in our laboratory.
Finally, we demonstrate that BGP-15 administration is able to
completely inhibit the rapid HSF1 acetylation observed during the
early phase of heat stress, thereby very likely promoting a
prolonged duration of HSF1 binding to HSE on hsp genes [22]
as shown first for Bimoclomol [21]. Again, additional studies are
needed to elucidate the precise mechanisms through which the
drug improves the transcriptional competence of HSF1.
Earlier Csermely and co-workers proposed that drug molecules
with multiple targets might have a better chance of affecting the
complex equilibrium of whole cellular networks than those acting
on a single target. In addition, low-affinity, multi-target drugs were
suggested to possess another advantage. Namely, they can increase
the number of weak links in preexisting cellular networks and thus
stabilize these networks in addition to having multiple effects [41].
In fact, weak links have been shown to stabilize complex networks,
including macromolecular networks, and cell membrane is
typically such a weak link-controlled macromolecular network.
Based on these models, we suggest that BGP-15 is typically a
multi-target low-affinity drug. BGP-15 was shown to inhibit the
caspase-independent programmed cell death in acetaminophen-
induced liver injury [42], and exerted also an effect through
modulation of poly(ADP-ribose) polymerase [43]. It is noted, that
if multi-target, low-affinity drugs inhibit their targets, they change
a strong link into a weak link instead of eliminating the link
completely.
Taken together, the non-proteotoxic, lipid-interacting multi-
target BGP-15 has a great potential to become a member of a new
class of pharmaceuticals for use in ‘membrane-lipid therapy’ to
combat most various protein-misfolding diseases and aging.
Materials and Methods
Cell culturing
B16-F10 mouse melanoma cell line (American Type Culture
Collection, strain C57BL/6J) were cultured in RPMI 1640
medium supplemented with 10% FCS and 4 mM L-glutamine.
Human Embryonic Kidney (HEK293T) cells (American Type
Culture Collection) were grown in DMEM medium supplemented
with 10% FCS. CHO cells stably transfected with mGFP-GPI
plasmid [19] were cultured as in [19]. BGP-15 was a gift of N-
Gene Research Laboratories, Inc. Budapest, Hungary.
Molecular modeling
All-atom lipid bilayer model was used as membrane model. The
systems studied were asymmetric membranes made of SM: N-
octadecanoyl-D-erythro-sphingosylphosphorylcholine and Chol
with/without BGP-15 at pH=7. The SM/Chol membranes were
made of 30 SM and 23 Chol molecules in one, and of 19 SM and
26 Chol molecules in the other leaflet. 5 BGP-15 molecules were
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X=101.27 A ˚, Y=6.66 A ˚, and Z=46.26 A ˚. 4080 molecules of
water to reach the density of 0.997 g/mL have been added. The
simulations were carried out with the program YASARA 10.10.28
[44] under NPT ensemble at 310K and 1 atm by coupling the
system with a Berendsen thermostat [45] and by controlling the
pressure in the manometer pressure control mode. The AM-
BER03 force field was used. The geometry of the molecules was
optimized by semi-empirical PM3 method using the COSMO
salvation [46]. Partial atomic charges were calculated using the
same level of theory by the Mulliken point charge approach [47].
Electrostatic interactions were calculated with a cutoff of 7.86 A ˚,
and the long-range electrostatic interactions were handled by the
Particle Mesh Ewald (PME) [48] algorithm using a sixth-order B-
spline interpolation and a grid spacing of 1 A ˚. The leap-frog
algorithm was used in all simulations with a 1.2 fs time step for
intramolecular forces and 2.4 fs time step for intermolecular forces
and the equilibration period was 5 ns. The lipid bilayers were
assembled and relaxed reducing the box dimension till the Van der
Waals energy of the system started to increase and the structural
parameters of the membranes were comparable to the experi-
mental data [49]. To study the distribution and favorable
localization of BGP-15 in a lipid membrane, we applied
unconstrained atomistic MD simulations based on passive
distribution of probe molecules between bulk water and bilayers.
We placed 10 molecules of BGP-15 at random locations and
orientations in bulk solution at the vicinity of 5–8 A ˚ from a bilayer
surface. To remove high energy contacts, the system was
equilibrated at NPT conditions for 5 ns. The membranes were
monitored overall the simulation in terms of structural and
physical parameters and controlled the thickness, area per lipid
and water density adhered to experimental values. The molecules
of BGP-15 that were placed at random distances docked to the
membrane in the first nanosecond of all simulations.
Monolayer experiments
Monolayer experiments were carried out with a KSV3000
Langmuir-Blodget instrument (KSV, Finland) in a teflon trough
(17 cm615 cm) at 23uC. Surface pressure was measured by the
Wilhelmy method using a platinum plate. Monomolecular lipid
layers of egg sphingomyelin (SM) (Larodan, Malmo ¨, Sweden),
dihydrocholesterol (DChol) (SUPELCO, Sigma-Aldrich, St. Louis,
MO, USA) and SM/DChol=1:1 (mol/mol) were spread from
chloroform solution (1 mgNmL
21) on a PBS subphase (pH 7.2)
which was continuously stirred with a magnetic bar. The surface
area was held constant until the surface pressure reached an
equilibrium after which an initial surface pressure of 22 mN/m)
was set and kept constant by changing the monolayer area (barrier
speed 4 mm/min). The initial surface pressure is chosen so as to be
well above the critical pressure in the phase diagrams of SM/
DChol mixtures [23]. BGP-15 (N-Gene, MW=351,28) was
injected under the subphase to get the final concentrations (0, 5,
10, 50, 100 mM ). Methyl b-cyclodextrin (MBCD) (CycloLab,
Mw=1303,4) was added from 100 mM stock in PBS to the
subphase to get a final concentrations of 10 mM. Desorption,
measured at 22 mN/m was estimated by the area change defined
as At/A0, where A0 and At are the monolayer area occupied by
lipids before and after the injection of MBCD, respectively [25].
Single molecule microscopy and data analysis
mGFP-GPI-expressing CHO cells were plated onto 30 mm
glass slides (#1, Menzel, Braunschweig, Germany) in Petri dishes
and incubated overnight in normal growth medium. These slides
covered by cells were replaced into POCmini chamber system
(LaCon, Staig, Germany) and filled up with preheated growth
medium with or without 10 mM BGP-15. Measurements were
performed in an accurately thermostated home-built incubator
box equipped with a heating unit, a temperable stage insert and an
objective heater (Pecon, Erbach, Germany). Measurements were
made either at 37 or 39.5uC. Single molecule microscopy setup,
measurements and data analysis were described in detail
previously [19,50]. Briefly, a Zeiss Axiovert 200 microscope was
equipped with a 1006 NA=1.46 a Plan - APOCHROMAT
objective (Zeiss, Oberkochen, Germany). Samples were illuminat-
ed in objective-based total internal reflection (TIR) configuration
using 488 nm light for excitation. A custom-made program
package implemented in LABVIEW (National Instruments,
Austin, TX) was used for timing and controlling the microscope
setup. Number of fluorescent probes within a single spots was
calculated by an in-house algorithms implemented in MATLAB
(MathWorks, Natick, MA). Subsequently the percentage of
monomer fraction (one mGFP-GPI per a single spot) and cluster
fraction (two or more fluorophores per a domain) was determined.
Experiment with low or high cell number cells
B16-F10 cell were plated at high (HCN=6610
6/10 cm
diameter Petri dish) or low (LCN=0.75610
6/10 cm diameter
Petri dish) initial cell number.
Quantitative real-time RT-PCR
Relative quantities of hsp25 mRNAs were determined and
normalized to b-actin as in [13].
fPEG-Chol labeling
B16-F10 melanoma cells were labeled with fPEG-Chol (kindly
provided by T. Kobayashi) and images were taken by CytoScout
fluorescent microscope. 200 nM fPEG-cholesterol (kindly provid-
ed by T. Kobayashi) labeling solution was prepared in PBS. B16-
F10 cells were grown in glass-bottom dishes with two different
initial cell densities: low initial cell number, LCN: 0.75610
6 and
high initial cell number, HCN: 6610
6. In the case of BGP-15
pretreatment 10 mM BGP-15 was added to cells before the
labeling for 20 min. Samples were labeled with the labeling
solution for 15 min at room temperature. After washing fresh
RPMI without phenol-red was added to cells and images were
taken by CytoScout fluorescent microscope. Samples were
illuminated in objective-based total internal reflection (TIR)
configuration using 488 nm light for excitation, images were
analyzed in CellProfiler (www.CellProfiler.org) and ImageJ
software (http://rsbweb.nih.gov/ij/). Both the mean fluorescent
intensity and the size (theoretical diameter) of each single detected
microdomain were calculated. The domains we found were sorted
into classes according to theoretical diameter. Diameters were
calculated as 2X * (Npix/p)-2, where X is the size of a pixel in nm
and Npix is the number of pixels covering the actual domain.
Rac1 inhibitor assay
B16-F10 cells were treated with 100 mM Rac1-specific inhibitor,
NSC23766 (Santa Cruz Biotechnology, USA) for 2 hours. It was
followed by 1 hour heat shock at 41.5uC along with/without
10 mM of BGP-15. After overnight recovery at 37uC, cell lysates
were prepared in Laemmli Buffer. Equal amounts of proteins were
loaded to 15% SDS gel and transferred to PVDF membrane.
Membranes were probed with anti HSP25 antibody (SPA 801),
Stressgen). Expression levels were visualized with Enhanced
Chemiluminescence (Amersham, USA). Band intensities were
measured with Alpha View Software v.1.3.0.7. (Alpha Innotech,
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HSP25.
HSF1 acetylation assay
HEK293T cells were transiently co-transfected with mouse
HSF1-FLAG and p300 (gift of S. Westerheide) as in [22]. 48 hours
after transfection, cells were preincubated for 1 hour with 10 mM
BGP-15 after which 1 hour heat shock at 42uC was applied.
Immediately after heat shock or after one hour recovery at 37uC,
cell lysates were prepared in standard RIPA buffer and HSF1-
FLAG was pulled down overnight at 4uC with anti-FLAG M2
affinity gel beads (Sigma, F2426). Acetylated-HSF1 or total FLAG
was determined by western blotting with an anti-acetylated-lysine
antibody (Cell Signaling, #9441) or anti-FLAG M2 antibody
(Sigma, F1804), respectively. Expression levels were determined as
above for HSP25. Band intensities were expressed as the ratio of
acetylated-HSF1 over FLAG as obtained in the same pull down
reaction and the ratio obtained at 37uC was considered as 1. Data
are expressed as mean and standard error of the mean (SEM).
Fluor de Lys SIRT1-deacetylase assay
Fluor-de Lys deacetylase assay kit (Biomol International, USA)
was used to analyze the direct effect of BGP-15 on the deacetylase
activity of recombinant SIRT1 according to the manual.
Nicotinamide was added to the reaction at the concentration of
2 mM when necessary. The final fluorescence was measured in a
Fluoroskan Ascent FL fluorometer (Thermo Fisher Scientific,
USA).
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